Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis)
Condition(s):Cystic FibrosisLast Updated:June 30, 2011Terminated
Hide Studies Not Open or Pending
Condition(s):Cystic FibrosisLast Updated:June 30, 2011Terminated
Condition(s):Prostate CancerLast Updated:November 24, 2023Completed
Condition(s):Prostatic NeoplasmsLast Updated:September 30, 2008Unknown status
Condition(s):Pancreatic CancerLast Updated:March 1, 2021Completed
Condition(s):Breast CancerLast Updated:February 8, 2017Completed
Condition(s):Coronary Artery DiseaseLast Updated:August 5, 2019Completed
Condition(s):Kidney Cancer; Melanoma (Skin)Last Updated:April 10, 2015Completed
Condition(s):Prostate CancerLast Updated:June 29, 2010Completed
Condition(s):Breast CancerLast Updated:June 22, 2023Completed
Condition(s):Recurrent Bladder Carcinoma; Stage I Bladder Cancer AJCC v6 and v7; Stage II Bladder Cancer AJCC v6 and v7; Stage III Bladder Cancer AJCC v6 and v7Last Updated:June 10, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.